Adherence of long-term breast cancer survivors to follow-up care guidelines : a study based on real-world data from the SURBCAN cohort
Santiá, Paula (Institut Hospital del Mar d'Investigacions Mèdiques)
Jansana, Anna (Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC))
del Cura, Isabel (Universidad Rey Juan Carlos)
Padilla-Ruiz, María (Universidad de Málaga)
Domingo, Laia (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Louro, Javier (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Comas, Mercè (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol)
Sanz Cuesta, Teresa (Instituto de Salud Carlos III)
Duarte-Salles, Talita 1985- (Institut Universitari d'Investigació en Atenció Primària Jordi Gol)
Redondo, Maximino (Universidad de Málaga)
Ibañez, Berta (Universidad Pública de Navarra)
Prados-Torres, Alexandra (Hospital Universitario Miguel Servet (Saragossa))
Castells, Xavier (Instituto de Salud Carlos III)
Sala, Maria (Instituto de Salud Carlos III)

Data:	2022
Resum:	To identify adherence to follow-up recommendations in long-term breast cancer survivors (LTBCS) of the SURBCAN cohort and to identify its determinants, using real-world data. We conducted a retrospective study using electronic health records from 2012 to 2016 of women diagnosed with incident breast cancer in Spain between 2000 and 2006 and surviving at least 5 years. Adherence to basic follow-up recommendations, adherence according to risk of recurrence, and overall adherence were calculated based on attendance at medical appointments and imaging surveillance, by year of survivorship. Logistic regression models were fitted to depict the association between adherence and its determinants. A total of 2079 LTBCS were followed up for a median of 4. 97 years. Of them, 23. 6% had survived ≥ 10 years at baseline. We estimated that 79. 5% of LTBCS were overall adherent to at least one visit and one imaging test. Adherence to recommendations decreased over time and no differences were found according to recurrence risk. Determinants of better overall adherence were diagnosis in middle age (50-69 years old), living in a more-deprived area, having fewer years of survival, receiving primary treatment, and being alive at the end of follow-up. We identified women apparently not complying with surveillance visits and tests. Special attention should be paid to the youngest and eldest women at diagnosis and to those with longer survival.
Ajuts:	Instituto de Salud Carlos III PI16/0024 Instituto de Salud Carlos III PI19/00056
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Guideline adherence ; Long-term survivors ; Cancer survivors ; Breast neoplasms ; Aftercare ; Mammography
Publicat a:	Breast Cancer Research and Treatment, Vol. 193 (march 2022) , p. 455-465, ISSN 1573-7217

DOI: 10.1007/s10549-022-06563-x
PMID: 35290544

11 p, 696.7 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats